PALI · Palisade Bio Inc
United States · RS rating 16 · As of 2026-11-03
| Price | 1.23 USD |
|---|---|
| 1-day change | +9.8% |
| RS rating (overall / 1M / 3M / 12M) | 16 / 26 / 12 / 26 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 23 / 5 / 29 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +56.1% |
| Market cap (USD) | $363.7M |